BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15341968)

  • 1. Estrone formate: a novel type of irreversible inhibitor of human steroid sulfatase.
    Schreiner EP; Billich A
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4999-5002. PubMed ID: 15341968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase.
    Woo LW; Howarth NM; Purohit A; Hejaz HA; Reed MJ; Potter BV
    J Med Chem; 1998 Mar; 41(7):1068-83. PubMed ID: 9544207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors.
    Lawrence Woo LW; Leblond B; Purohit A; Potter BV
    Bioorg Med Chem; 2012 Apr; 20(8):2506-19. PubMed ID: 22455789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boronic acids as inhibitors of steroid sulfatase.
    Ahmed V; Liu Y; Silvestro C; Taylor SD
    Bioorg Med Chem; 2006 Dec; 14(24):8564-73. PubMed ID: 16973364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-difluoromethyloestrone 3-O-sulphamate, a highly potent steroid sulphatase inhibitor.
    Reed JE; Woo LW; Robinson JJ; Leblond B; Leese MP; Purohit A; Reed MJ; Potter BV
    Biochem Biophys Res Commun; 2004 Apr; 317(1):169-75. PubMed ID: 15047163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of steroid sulfatase with 4-substituted estrone and estradiol derivatives.
    Phan CM; Liu Y; Kim BM; Mostafa Y; Taylor SD
    Bioorg Med Chem; 2011 Oct; 19(20):5999-6005. PubMed ID: 21925885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activity of the superestrogen (E)-17-oximino-3-O-sulfamoyl-1,3,5(10)-estratriene: x-ray crystal structure of (E)-17-oximino-3-hydroxy-1,3,5(10)-estratriene.
    Hejaz HA; Purohit A; Mahon MF; Reed MJ; Potter BV
    J Med Chem; 1999 Aug; 42(16):3188-92. PubMed ID: 10447965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of estrone sulfate-induced uterine growth by potent nonestrogenic steroidal inhibitors of steroid sulfatase.
    Ciobanu LC; Luu-The V; Martel C; Labrie F; Poirier D
    Cancer Res; 2003 Oct; 63(19):6442-6. PubMed ID: 14559834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid sulfatase: molecular biology, regulation, and inhibition.
    Reed MJ; Purohit A; Woo LW; Newman SP; Potter BV
    Endocr Rev; 2005 Apr; 26(2):171-202. PubMed ID: 15561802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of novel steroid sulfatase inhibitors; II. TZS-8478 potently inhibits the growth of breast tumors in postmenopausal breast cancer model rats.
    Saito T; Kinoshita S; Fujii T; Bandoh K; Fuse S; Yamauchi Y; Koizumi N; Horiuchi T
    J Steroid Biochem Mol Biol; 2004 Feb; 88(2):167-73. PubMed ID: 15084348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of steroid sulfatase inhibitors.
    Woo LW; Purohit A; Potter BV
    Mol Cell Endocrinol; 2011 Jul; 340(2):175-85. PubMed ID: 21238537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo activity of 4-methylcoumarin-7-O-sulfamate, a nonsteroidal, nonestrogenic steroid sulfatase inhibitor.
    Purohit A; Woo LW; Singh A; Winterborn CJ; Potter BV; Reed MJ
    Cancer Res; 1996 Nov; 56(21):4950-5. PubMed ID: 8895749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17alpha-benzyl(or 4'-tert-butylbenzyl)estra-1,3,5(10)-trienes: combination of two substituents at positions C3 and c17alpha of estradiol.
    Ciobanu LC; Boivin RP; Luu-The V; Labrie F; Poirier D
    J Med Chem; 1999 Jun; 42(12):2280-6. PubMed ID: 10377235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid sulfatase inhibitors.
    Nussbaumer P; Billich A
    Med Res Rev; 2004 Jul; 24(4):529-76. PubMed ID: 15170594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First crystal structures of human carbonic anhydrase II in complex with dual aromatase-steroid sulfatase inhibitors.
    Lloyd MD; Thiyagarajan N; Ho YT; Woo LW; Sutcliffe OB; Purohit A; Reed MJ; Acharya KR; Potter BV
    Biochemistry; 2005 May; 44(18):6858-66. PubMed ID: 15865431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, in vitro and in vivo activity of benzophenone-based inhibitors of steroid sulfatase.
    Hejaz HA; Woo LW; Purohit A; Reed MJ; Potter BV
    Bioorg Med Chem; 2004 May; 12(10):2759-72. PubMed ID: 15110857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential.
    Thomas MP; Potter BV
    J Steroid Biochem Mol Biol; 2015 Sep; 153():160-9. PubMed ID: 25843211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-ring modified estrone derivatives as novel potent inhibitors of steroid sulfatase.
    Fischer DS; Woo LW; Mahon MF; Purohit A; Reed MJ; Potter BV
    Bioorg Med Chem; 2003 Apr; 11(8):1685-700. PubMed ID: 12659755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nature of inhibition of steroid sulphatase activity by tibolone and its metabolites.
    Raobaikady B; Day JM; Purohit A; Potter BV; Reed MJ
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):229-37. PubMed ID: 15862970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate.
    Purohit A; Williams GJ; Howarth NM; Potter BV; Reed MJ
    Biochemistry; 1995 Sep; 34(36):11508-14. PubMed ID: 7547880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.